107 related articles for article (PubMed ID: 15645124)
1. BRD-glucan exhibits potent immunochemotherapeutic activity in vitro and in vivo.
Moon SH; Heo JC; Fine RL; Kim HM; Kim SU; Yoon BD; Lee SH
Int J Oncol; 2005 Feb; 26(2):395-404. PubMed ID: 15645124
[TBL] [Abstract][Full Text] [Related]
2. Immune receptors for polysaccharides from Ganoderma lucidum.
Shao BM; Dai H; Xu W; Lin ZB; Gao XM
Biochem Biophys Res Commun; 2004 Oct; 323(1):133-41. PubMed ID: 15351712
[TBL] [Abstract][Full Text] [Related]
3. Immunomodulatory oligonucleotides containing a cytosine-phosphate-2'-deoxy-7-deazaguanosine motif as potent toll-like receptor 9 agonists.
Kandimalla ER; Bhagat L; Li Y; Yu D; Wang D; Cong YP; Song SS; Tang JX; Sullivan T; Agrawal S
Proc Natl Acad Sci U S A; 2005 May; 102(19):6925-30. PubMed ID: 15860583
[TBL] [Abstract][Full Text] [Related]
4. Immunomodulatory activity of polysaccharides isolated from Strongylocentrotus nudus eggs.
Liu C; Xi T; Lin Q; Xing Y; Ye L; Luo X; Wang F
Int Immunopharmacol; 2008 Dec; 8(13-14):1835-41. PubMed ID: 18834960
[TBL] [Abstract][Full Text] [Related]
5. Anti-tumor metastatic activity of beta-glucan purified from mutated Saccharomyces cerevisiae.
Yoon TJ; Kim TJ; Lee H; Shin KS; Yun YP; Moon WK; Kim DW; Lee KH
Int Immunopharmacol; 2008 Jan; 8(1):36-42. PubMed ID: 18068098
[TBL] [Abstract][Full Text] [Related]
6. Pectic polysaccharide isolated from Angelica gigas Nakai inhibits melanoma cell metastasis and growth by directly preventing cell adhesion and activating host immune functions.
Han SB; Lee CW; Kang MR; Yoon YD; Kang JS; Lee KH; Yoon WK; Lee K; Park SK; Kim HM
Cancer Lett; 2006 Nov; 243(2):264-73. PubMed ID: 16412568
[TBL] [Abstract][Full Text] [Related]
7. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.
Hoch U; Lynch J; Sato Y; Kashimoto S; Kajikawa F; Furutani Y; Silverman JA
Cancer Chemother Pharmacol; 2009 Jun; 64(1):53-65. PubMed ID: 18931998
[TBL] [Abstract][Full Text] [Related]
8. Targeting toll-like receptor 9 with CpG oligodeoxynucleotides enhances tumor response to fractionated radiotherapy.
Mason KA; Ariga H; Neal R; Valdecanas D; Hunter N; Krieg AM; Whisnant JK; Milas L
Clin Cancer Res; 2005 Jan; 11(1):361-9. PubMed ID: 15671567
[TBL] [Abstract][Full Text] [Related]
9. Antitumor and antimetastatic activity of a novel water-soluble low molecular weight beta-1, 3-D-glucan (branch beta-1,6) isolated from Aureobasidium pullulans 1A1 strain black yeast.
Kimura Y; Sumiyoshi M; Suzuki T; Sakanaka M
Anticancer Res; 2006; 26(6B):4131-41. PubMed ID: 17201124
[TBL] [Abstract][Full Text] [Related]
10. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
11. Characterization of B cell membrane receptors of polysaccharide isolated from the root of Acanthopanax koreanum.
Han SB; Park SK; Ahn HJ; Yoon YD; Kim YH; Lee JJ; Lee KH; Moon JS; Kim HC; Kim HM
Int Immunopharmacol; 2003 May; 3(5):683-91. PubMed ID: 12757737
[TBL] [Abstract][Full Text] [Related]
12. Differential immune effects mediated by Toll-like receptors stimulation in precursor B-cell acute lymphoblastic leukaemia.
Corthals SL; Wynne K; She K; Shimizu H; Curman D; Garbutt K; Reid GS
Br J Haematol; 2006 Feb; 132(4):452-8. PubMed ID: 16412017
[TBL] [Abstract][Full Text] [Related]
13. Activation of Toll-like receptor 4 on tumor cells in vitro inhibits subsequent tumor growth in vivo.
Andreani V; Gatti G; Simonella L; Rivero V; Maccioni M
Cancer Res; 2007 Nov; 67(21):10519-27. PubMed ID: 17974996
[TBL] [Abstract][Full Text] [Related]
14. [Anti-tumor effect of monkshood polysaccharide with adriamycin long circulating temperature-sensitive liposome and its mechanism].
Dong LF; Zhang YJ; Liu JS; Song SX; Hou J; Lu ZJ
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Jul; 22(4):458-62. PubMed ID: 16806008
[TBL] [Abstract][Full Text] [Related]
15. Activation of tumor-associated macrophages by the vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid induces an effective CD8+ T-cell-mediated antitumor immune response in murine models of lung cancer and mesothelioma.
Jassar AS; Suzuki E; Kapoor V; Sun J; Silverberg MB; Cheung L; Burdick MD; Strieter RM; Ching LM; Kaiser LR; Albelda SM
Cancer Res; 2005 Dec; 65(24):11752-61. PubMed ID: 16357188
[TBL] [Abstract][Full Text] [Related]
16. Toll-like receptor 2 stimulation induces intimal hyperplasia and atherosclerotic lesion development.
Schoneveld AH; Oude Nijhuis MM; van Middelaar B; Laman JD; de Kleijn DP; Pasterkamp G
Cardiovasc Res; 2005 Apr; 66(1):162-9. PubMed ID: 15769459
[TBL] [Abstract][Full Text] [Related]
17. Melanoma inhibits macrophage activation by suppressing toll-like receptor 4 signaling.
Clarke JH; Cha JY; Walsh MD; Gamboni-Robertson F; Banerjee A; Reznikov LL; Dinarello CA; Harken AH; McCarter MD
J Am Coll Surg; 2005 Sep; 201(3):418-25. PubMed ID: 16125076
[TBL] [Abstract][Full Text] [Related]
18. Cyclophosphamide enhances the antitumor efficacy of adoptively transferred immune cells through the induction of cytokine expression, B-cell and T-cell homeostatic proliferation, and specific tumor infiltration.
Bracci L; Moschella F; Sestili P; La Sorsa V; Valentini M; Canini I; Baccarini S; Maccari S; Ramoni C; Belardelli F; Proietti E
Clin Cancer Res; 2007 Jan; 13(2 Pt 1):644-53. PubMed ID: 17255288
[TBL] [Abstract][Full Text] [Related]
19. Phenothiazines induce apoptosis in a B16 mouse melanoma cell line and attenuate in vivo melanoma tumor growth.
Gil-Ad I; Shtaif B; Levkovitz Y; Nordenberg J; Taler M; Korov I; Weizman A
Oncol Rep; 2006 Jan; 15(1):107-12. PubMed ID: 16328041
[TBL] [Abstract][Full Text] [Related]
20. Up-regulation of cell surface Toll-like receptor 4-MD2 expression on dendritic epidermal T cells after the emigration from epidermis during cutaneous inflammation.
Shimura H; Nitahara A; Ito A; Tomiyama K; Ito M; Kawai K
J Dermatol Sci; 2005 Feb; 37(2):101-10. PubMed ID: 15659328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
